{"context":{"query":">>mondo>>clinical_trials","source_dataset":"mondo","target_dataset":"clinical_trials"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]MONDO:0008487,73,MONDO:0008487,109,-1]["},"schema":"id|brief_title|overall_status|phase|study_type","mappings":[{"input":"MONDO:0008487","source":"MONDO:0008487|polycystic ovary syndrome","targets":["NCT00145340|Pioglitazone Treatment in Polycystic Ovary Syndrome|COMPLETED|PHASE4|INTERVENTIONAL","NCT00159575|Metformin in Assisted Reproduction-MET-AR-study|TERMINATED|PHASE4|INTERVENTIONAL","NCT00203996|Polycystic Ovary Syndrome (PCOS) and Sleep Apnea|TERMINATED|PHASE4|INTERVENTIONAL","NCT00378729|Surgical Ovarian Drilling Versus Hormonal Treatment for Infertility Associated to PolyCystic Ovaries Syndrome (PCOS)|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00417144|Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00428311|Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS|COMPLETED|PHASE4|INTERVENTIONAL","NCT00437333|Metformin Suspension and Insulin Sensitivity|COMPLETED|PHASE4|INTERVENTIONAL","NCT00451568|Metformin and Oral Contraceptives in PCOS|COMPLETED|PHASE4|INTERVENTIONAL","NCT00463112|Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOS|COMPLETED|PHASE4|INTERVENTIONAL","NCT00471523|Treatment of Anovulatory Infertility in PCOS Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT00473538|Structured Exercise Training Program Versus Hypocaloric Hyperproteic Diet in Obese Anovulatory Infertile Patients With PCOS|COMPLETED|PHASE4|INTERVENTIONAL","NCT00501787|Metformin Administration in Infertile Anovulatory PCOS Patients|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT00501839|Clomiphene Citrate in Infertile PCOS Patients|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT00501904|Metformin in Infertile PCOS Patients|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00502229|Therapy for Infertile PCOS Patients Ovulating Under Clomiphene Citrate or Metformin|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT00502281|Controlled Ovarian Stimulation Followed by Timed Intercourse or Intrauterine Insemination in Infertile PCOS Patients|SUSPENDED|PHASE4|INTERVENTIONAL","NCT00558077|Second-Line Treatments for Anovulatory Infertility in PCOS Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT00593294|Oral Contraceptive and Cardiovascular Risk in PCOS|COMPLETED|PHASE4|INTERVENTIONAL","NCT00620529|The Effects of Fish Oils on Blood Pressure, Heart Rate Variability and Liver Fat in the Polycystic Ovary Syndrome|COMPLETED|PHASE4|INTERVENTIONAL","NCT00640224|Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study|COMPLETED|PHASE4|INTERVENTIONAL","NCT00679679|Metformin and Lifestyle Intervention in Women With Polycystic Ovary Syndrome|COMPLETED|PHASE4|INTERVENTIONAL","NCT00682890|Combination Metformin and Oral Contraception for Polycystic Ovary Syndrome (PCOS)|TERMINATED|PHASE4|INTERVENTIONAL","NCT00703092|Pilot Study:Role of Dietary Fiber in PCOS Anovulation|TERMINATED|PHASE4|INTERVENTIONAL","NCT00795808|PCOSMIC Trial - PolyCystic Ovary Syndrome, Metformin for Infertility With Clomiphene|COMPLETED|PHASE4|INTERVENTIONAL","NCT00883259|Metformin and Gestational Diabetes in High-risk Patients: a RCTs|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00953355|Metformin and Folate Supplementation in Polycystic Ovary Syndrome (PCOS) Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT01004068|Short-term Structured Exercise Training Program Plus Diet Intervention in Patients With Polycystic Ovary Syndrome (PCOS)|COMPLETED|PHASE4|INTERVENTIONAL","NCT01021579|Effects of Metformin Plus Simvastatin on Polycystic Ovarian Syndrome (PCOS): A Prospective, Randomized, Double-Blind, Placebo-Controlled Study|COMPLETED|PHASE4|INTERVENTIONAL","NCT01115140|Metformin and Folate in Pregnant Polycystic Ovary Syndrome(PCOS) Women|COMPLETED|PHASE4|INTERVENTIONAL","NCT01118598|Effect of Nicotinic Acid on Cardiovascular Risks Indices in Polycystic Ovary Syndrome|COMPLETED|PHASE4|INTERVENTIONAL","NCT01208740|Metformin in Patients With PCOS and Predictors of Poor Ovarian Response Ongoing In-vitro Fertilization|TERMINATED|PHASE4|INTERVENTIONAL","NCT01233206|Metformin in High Responder Polycystic Ovary Syndrome (PCOS) Patients Undergoing IVF Cycles|COMPLETED|PHASE4|INTERVENTIONAL","NCT01360996|Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism|COMPLETED|PHASE4|INTERVENTIONAL","NCT01365936|hMG or Recombinant FSH on OHSS Prevention in PCOS Patients Undergoing IVF|COMPLETED|PHASE4|INTERVENTIONAL","NCT01366391|Therapeutic Monitoring of Metformin in Women With Polycystic Ovary Syndrome|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01438190|Metformin in Step-down Regimen Versus Conventional Low Dose Step-up Protocol in Patients With PCOS Undergoing IVF|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01504321|Polycystic Ovary Syndrome - Improving Outcomes|COMPLETED|PHASE4|INTERVENTIONAL","NCT01511822|Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance|COMPLETED|PHASE4|INTERVENTIONAL","NCT01514942|Myo-inositol Versus D-chiro-inositol in the Treatment of Polycystic Ovary Syndrome and Insulin Resistance: Evaluation of Clinical, Metabolic, Endocrine and Ultrasound Parameters|COMPLETED|PHASE4|INTERVENTIONAL","NCT01540747|Role of Melatonin Supplementation in Follicular Fluid of in Vitro Fertilization (IVF) Patients With Polycystic Ovarian Syndrome|COMPLETED|PHASE4|INTERVENTIONAL","NCT01626443|Role of Myo-inositol and D-chiro Inositol on the Ovaric and Metabolic Functions|COMPLETED|PHASE4|INTERVENTIONAL","NCT01683513|Trial Comparing hCG Triggering Versus GnRH Agonist Triggering in PCOS Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT01721915|Vitamin D Treatment, Pharmacogenetics and Glucose Metabolism|COMPLETED|PHASE4|INTERVENTIONAL","NCT01752270|the Effect of Diane-35 Pretreatment on In-vitro Fertilization Outcome for Patients With Polycystic Ovary Syndrome|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01798875|PCOS, Therapy and Markers of Cardiovascular Risk|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01892254|Incretin Effect in PCOS Women|COMPLETED|PHASE4|INTERVENTIONAL","NCT01896492|Clomiphene Plus N-acetyl Cysteine for Induction of Ovulation in Newly Diagnosed Pcos.|COMPLETED|PHASE4|INTERVENTIONAL","NCT01899430|Polycystic Ovary Syndrome and Liraglutide|COMPLETED|PHASE4|INTERVENTIONAL","NCT01911468|Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin|COMPLETED|PHASE4|INTERVENTIONAL","NCT01961180|The Effect of Cipralex on Quality of Life, Adrenal Activity Glucose Metabolism, Physical and Mental Health in PCOS|COMPLETED|PHASE4|INTERVENTIONAL","NCT01966575|Effect of Progestin-Induced Withdrawal Bleed on Ovulation Induction Cycles With Clomiphene Citrate|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT02037672|PDE-4 Inhibitor Roflumilast and Polycystic Ovary Syndrome|COMPLETED|PHASE4|INTERVENTIONAL","NCT02073929|LIPT - Liraglutide in Polycystic Ovary Syndrome|COMPLETED|PHASE4|INTERVENTIONAL","NCT02122380|The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome|COMPLETED|PHASE4|INTERVENTIONAL","NCT02187250|PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome|COMPLETED|PHASE4|INTERVENTIONAL","NCT02221154|Use of Myo-inositol as Adjuvant Therapy in Patients With Polycystic Ovary Syndrome (PCOS) in Vitro Fertilization (IVF)|TERMINATED|PHASE4|INTERVENTIONAL","NCT02239107|N-acetyl Cysteine for Ovulation Induction in Clomiphene Citrate Resistant Polycystic Ovary Syndrome|COMPLETED|PHASE4|INTERVENTIONAL","NCT02280057|Trial With Metformin in Women With Polycystic Ovary Syndrome|COMPLETED|PHASE4|INTERVENTIONAL","NCT02352597|Phytoestrogens as an Alternative to Estradiol in Ovulation Induction in PCOS|COMPLETED|PHASE4|INTERVENTIONAL","NCT02460380|The Effects of Vitamin D on Angiogenic Factors in Women With Polycystic Ovary Syndrome|COMPLETED|PHASE4|INTERVENTIONAL","NCT02479256|Clomiphene Citrate Versus Tamoxifen for Ovulation Induction in PCOs|COMPLETED|PHASE4|INTERVENTIONAL","NCT02483299|Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome|COMPLETED|PHASE4|INTERVENTIONAL","NCT02500147|Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)|TERMINATED|PHASE4|INTERVENTIONAL","NCT02683226|Comparison of Alogliptin Versus Alogliptin and Pioglitazone on Insulin Resistance of Metformin Treated Women With PCOS|COMPLETED|PHASE4|INTERVENTIONAL","NCT02785822|Study to Compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in Patients With Polycystic Ovary Under a IVF/ICSI Cycle.|TERMINATED|PHASE4|INTERVENTIONAL","NCT02802865|Combined Letrozole and Clomid in Women With Infertility and PCOS|COMPLETED|PHASE4|INTERVENTIONAL","NCT02866786|The Effects of OCP and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in PCOS|COMPLETED|PHASE4|INTERVENTIONAL","NCT02909933|Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity|COMPLETED|PHASE4|INTERVENTIONAL","NCT02941445|Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss|COMPLETED|PHASE4|INTERVENTIONAL","NCT03034941|Short Term Weight Loss With Liraglutide and Metformin in Infertile Obese PCOS Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT03122041|Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary Syndrome|COMPLETED|PHASE4|INTERVENTIONAL","NCT03151005|The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS|COMPLETED|PHASE4|INTERVENTIONAL","NCT03236740|OCP vs Metformin on Ovarian Stromal Blood Flow in PCOS|COMPLETED|PHASE4|INTERVENTIONAL","NCT03252223|Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS|COMPLETED|PHASE4|INTERVENTIONAL","NCT03325023|Effect of Dietary Modifacation on Microbiota in Overweight and Obese Polycystic Ovary Syndrome Patients|UNKNOWN|PHASE4|INTERVENTIONAL","NCT03352869|Research of Exenatide for Overweight/Obese PCOS Patients With IGR|COMPLETED|PHASE4|INTERVENTIONAL","NCT03353948|The Effect of a Liraglutide on IVF in Obese PCOS|COMPLETED|PHASE4|INTERVENTIONAL","NCT03380091|Metformin, Vitamin D, and Depression in Polycystic Ovary Syndrome (PCOS) Trial|TERMINATED|PHASE4|INTERVENTIONAL","NCT03383068|Research of Intensive Metabolic Intervention Before Pregnancy in PCOS|UNKNOWN|PHASE4|INTERVENTIONAL","NCT03486626|Endometrial Thickness and Subendometrial Vascularity in Anovulatory Polycystic Ovarian Syndrome Patients Treated by Metformin|UNKNOWN|PHASE4|INTERVENTIONAL","NCT03630341|Adding L-Carnitine to Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovary Syndrome|COMPLETED|PHASE4|INTERVENTIONAL","NCT03642600|The Gut Microbiome in Women With Polycystic Ovary Syndrome|COMPLETED|PHASE4|INTERVENTIONAL","NCT03644212|Vitamin D Increases Serum Levels of the Soluble Receptor for Advanced Glycation End Products in Women With PCOS|COMPLETED|PHASE4|INTERVENTIONAL","NCT03806036|The Effect Of Vitamin D Replacement Therapy On Serum Leptin And Follicular Growth Pattern In Women With Resistant Polycystic Ovary|UNKNOWN|PHASE4|INTERVENTIONAL","NCT03819140|Continuous Versus Cyclical OCP Use in PCOS|COMPLETED|PHASE4|INTERVENTIONAL","NCT03898934|Vitamin D Supplementation in PCOS Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT03989024|Pulsatile Gonadotropin-releasing Hormone for Infertility in Non-obese Patients With Polycystic Ovary Syndrome|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04002635|Letrozole for Frozen Embryo Transfer (FET) in Patients With Polycystic Ovary Syndrome (PCOS)|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT04010942|Vitamin D for Polycystic Ovary Syndrome Clomiphene Resistant Women|COMPLETED|PHASE4|INTERVENTIONAL","NCT04029272|Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04094467|Comparison Between Two Different Protocols in Polycystic Ovary Symdrome Women Undergoing Intra-cytoplasmic Injection|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04257500|Does Vaginal Delivery of Combined Hormonal Contraception Affect the Risk of Metabolic Syndrome in Overweight/Obese Women With PCOS|COMPLETED|PHASE4|INTERVENTIONAL","NCT04263415|The Effects of Semaglutide on Taste, Tongue Tissue Transcriptome, Gastric Emptying and Central Neural Response in Women With PCOS and Obesity|COMPLETED|PHASE4|INTERVENTIONAL","NCT04306692|Myo-inositol Versus Clomiphene Citrate in PCOS|TERMINATED|PHASE4|INTERVENTIONAL","NCT04453306|Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04508634|Treating Obese PCOS Patients With LSG vs. Met|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04593459|Probiotic Intervention in PCOS|COMPLETED|PHASE4|INTERVENTIONAL","NCT04700839|SGLT2 Inhibitors in Patients With PCOS|COMPLETED|PHASE4|INTERVENTIONAL","NCT04727671|Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.|COMPLETED|PHASE4|INTERVENTIONAL","NCT04727684|Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI|COMPLETED|PHASE4|INTERVENTIONAL"]}]}